Although anti-pituitary antibodies were present in patients with ipilimumab-related hypophysitis [17], the involvement of ADCC and complement activation has not been clarified in anti-CTLA-4-induced hypophysitis in humans. The gene discussed is CTLA4; the disease is hypophysitis.